SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-138958
Filing Date
2018-04-27
Accepted
2018-04-27 16:19:55
Documents
8
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d488059ddefa14a.htm DEFA14A 42745
2 GRAPHIC g488059pcpg02b.jpg GRAPHIC 1765
3 GRAPHIC g488059pcpg02c.jpg GRAPHIC 1773
4 GRAPHIC g488059pcpg02d.jpg GRAPHIC 1817
5 GRAPHIC g488059snap1.jpg GRAPHIC 1660
6 GRAPHIC g488059snap2.jpg GRAPHIC 1814
7 GRAPHIC g488059snap3.jpg GRAPHIC 1701
8 GRAPHIC g488059snap4.jpg GRAPHIC 1723
  Complete submission text file 0001193125-18-138958.txt   61663
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36152 | Film No.: 18784175
SIC: 2836 Biological Products, (No Diagnostic Substances)